ArticleInternal medicine (Tokyo, Japan)2025
Impact of Switching to New ResMed Devices on Continuous Positive Airway Pressure Therapy: A Multicenter Study.
Article in Internal medicine (Tokyo, Japan), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective ResMed has recently developed new continuous positive airway pressure (CPAP) devices, namely the AirSense 11 series. This study aimed to determine whether new ResMed devices have a more favorable impact on CPAP therapy than previous models. Methods This prospective multicenter study was conducted at Kyoto University Hospital, Rakuwakai Otowa Hospital, Shibata Clinic, and Hatta Medical Clinic. Patients with sleep apnea syndrome who used the previous generation of ResMed devices and switched to new ResMed devices from April 2023 to June 2024 were eligible to participate in the study. CPAP device data for one month before and after switching to new ResMed devices were downloaded using ResScan, NemLink, or f'Rens. Results A total of 102 patients were included in this analysis. The switch from old to new ResMed devices resulted in significant decreases in median CPAP pressure and 95th percentile leak from 8.1 (6.8-9.9) cmH
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.